S. Wigal

发表

Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

B. Shaywitz, S. Shaywitz, S. Hooper, 2013, Journal of child and adolescent psychopharmacology.

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

J. Swanson, J. Kennedy, G. Sunohara, 1998, Molecular Psychiatry.

Reading Performance as a Function of Treatment With Lisdexamfetamine Dimesylate in Elementary School Children Diagnosed With ADHD

Kimberley D. Lakes, Sabrina Schuck, Sharon B Wigal, 2012, Journal of attention disorders.

Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised

S. Faraone, S. Kollins, N. Desousa, 2018, Journal of attention disorders.

Laboratory School Protocol Mini-Review: Use of Direct Observational and Objective Measures to Assess ADHD Treatment Response Across the Lifespan

S. Wigal, 2019, Front. Psychol..

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.

D. Palumbo, P. Chappell, S. Wigal, 2020, Journal of child and adolescent psychopharmacology.

Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.

J. McGough, S. Wigal, D. Pierce, 2008, Journal of child and adolescent psychopharmacology.

Hematologic and Blood Biochemistry Monitoring During Methylphenidate Treatment in Children With Attention-Deficit/Hyperactivity Disorder: 2-Year, Open-Label Study Results

T. Wilens, M. Wolraich, S. Wigal, 2007, Pediatrics.

A Randomized, Double-Blind, Placebo-Controlled, Laboratory Classroom Assessment of Methylphenidate Transdermal System in Children With ADHD

J. McGough, H. Abikoff, S. Wigal, 2006, Journal of attention disorders.

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.

J. Swanson, I. Shoulson, Suneel K. Gupta, 2003, Archives of general psychiatry.

A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD.

J. Swanson, L. Greenhill, S. Wigal, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.

J. Swanson, J. McGough, J. McCracken, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

J. Swanson, R. Moyzis, J. McGough, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Prevalence of ADHD symptoms in patients with congenital heart disease

T. Wigal, S. Wigal, M. Lerner, 2012, Pediatrics international : official journal of the Japan Pediatric Society.

A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.

L. Greenhill, S. Kollins, S. Wigal, 2014, Journal of child and adolescent psychopharmacology.

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD

S. Segal, S. Kollins, R. Findling, 2011, Pediatrics.

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

T. Wilens, T. Wigal, E. Kohegyi, 2020, Neuropsychiatric disease and treatment.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

R. Findling, H. Abikoff, O. Bukstein, 2009, Clinical therapeutics.

Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, R. Moyzis, J. McGough, 2007, Journal of child and adolescent psychopharmacology.

The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications

J. Swanson, L. Greenhill, T. Wigal, 2002, Journal of attention disorders.

Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.

J. Swanson, L. Greenhill, D. Cantwell, 1998, Psychopharmacology bulletin.

Classification of types of tardive dyskinesia in a developmentally disabled population at a public residential facility

J. Swanson, S. Potkin, T. Wigal, 1993 .

Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers

L. Greenhill, S. Kollins, F. Sallee, 2014, Clinical Drug Investigation.

J. Swanson, J. McGough, J. McCracken, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use

Elizabeth B. Owens, Andrea L. Howard, J. Swanson, 2018, Journal of attention disorders.

The Novel Use of Objective Laboratory School Tasks to Measure Stress Responses in Children with ADHD

S. Wigal, A. Stehli, Carmen Truong, 2012, Postgraduate medicine.

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study

D. Palumbo, P. Chappell, S. Wigal, 2018, Journal of child and adolescent psychopharmacology.

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

J. Orazem, D. Palumbo, P. Chappell, 2017, Journal of child and adolescent psychopharmacology.

Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS)

J. Swanson, J. McGough, J. McCracken, 2007 .

The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment

T. Wigal, S. Wigal, A. Childress, 2020, Journal of attention disorders.

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

C A Sandman, S B Wigal, E G Jones, 1993, Archives of general psychiatry.

Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.

T. Roth, S. Kollins, A. Lyne, 2011, Journal of child and adolescent psychopharmacology.

Safety and tolerability of methylphenidate in preschool children with ADHD.

J. Swanson, J. McGough, J. McCracken, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.

L. Greenhill, J. Newcorn, S. Wigal, 2014, Journal of child and adolescent psychopharmacology.

Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall).

J. Swanson, L. Greenhill, D. Cantwell, 1998, Psychopharmacology bulletin.

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder

L. Greenhill, R. Findling, S. Wigal, 2015, Drug design, development and therapy.

NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.

S. Wigal, S. Berry, A. Childress, 2013, Journal of child and adolescent psychopharmacology.

The Laboratory School Protocol

T. Wigal, S. Wigal, 2006, Journal of attention disorders.

Lateralized attentional deficits in drug-free and medicated schizophrenic patients

J. Swanson, S. Potkin, S. Wigal, 1997, Neuropsychologia.

Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder.

J. Swanson, L. Greenhill, T. Wigal, 2007, Journal of child and adolescent psychopharmacology.

Analog classroom assessment of Adderall in children with ADHD.

J. Swanson, L. Greenhill, D. Cantwell, 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

Controversies surrounding pediatric psychopharmacology.

S. Wigal, Robin B Steinberg-Epstein, T. Book, 2011, Advances in pediatrics.

Sparing of patterned alternation but not partial reinforcement extinction effect after prenatal chronic exposure to ethanol in infant rats.

P. L. Greene, N. Lobaugh, A. Amsel, 1988, Behavioral neuroscience.

Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.

J. Swanson, J. Kennedy, G. Lahoste, 1996, Molecular psychiatry.

Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD

R. Findling, S. Wigal, S. Berry, 2017, Journal of attention disorders.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

J. Swanson, J. Biederman, L. Greenhill, 2004, Pediatrics.

Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-

J. Swanson, J. Zeldis, S. Wigal, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

I. Shoulson, Suneel K. Gupta, S. Wigal, 1999, Clinical pharmacology and therapeutics.

Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

Admissions to a public residential facility for individuals with developmental disabilities: Change in neuroleptic drug use and tardive dyskinesia

J. Swanson, T. Wigal, S. Wigal, 1994 .

Reliability and validity of the SKAMP rating scale in a laboratory school setting.

J. Swanson, S. Wigal, D. Guinta, 1998, Psychopharmacology bulletin.

Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial

B. Shaywitz, S. Shaywitz, S. Hooper, 2017, Journal of child and adolescent psychopharmacology.

Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study

J. Swanson, J. Biederman, L. Greenhill, 2005, Pediatrics.

Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.

J. McGough, J. McCracken, L. Greenhill, 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)

J. Newcorn, T. Wigal, E. Konofal, 2018, CNS Drugs.

Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.

J. McGough, J. McCracken, L. Greenhill, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder.

T. Wilens, H. Abikoff, M. Manos, 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study

L. Greenhill, S. Wigal, A. Childress, 2015, CNS Drugs.

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

S. Wigal, 2009, CNS Drugs.

Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

J. Swanson, J. McGough, J. McCracken, 2007, Journal of child and adolescent psychopharmacology.

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

J. McGough, J. Biederman, J. McCracken, 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder

S. Wigal, P. Raja, Ankita Shukla, 2013, Expert opinion on pharmacotherapy.

Special Considerations in Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder

T. Wigal, S. Wigal, 2007, CNS Spectrums.

Metabolic, toxicological, and safety considerations for drugs used to treat ADHD

S. Wigal, K. Chung, Sophie Duong, 2012, Expert opinion on drug metabolism & toxicology.

Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder.

W. Roberts, J. Swanson, J. Kennedy, 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

School (The Comacs Study) in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory A Comparison of Once-Daily Extended-Release Methylphenidate Formulations

J. Biederman, L. Greenhill, E. Sonuga-Barke, 2013 .

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

S. Wigal, M. Brams, S. Berry, 2017, Journal of child and adolescent psychopharmacology.

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study

R. Goldman, S. Wigal, A. Loebel, 2019, Journal of attention disorders.

ADouble-Blind, Placebo-Controlled Withdrawal Trial of Dexmethylphenidate Hydrochloride in Children with Attention Deficit Hyperactivity Disorder

S. West, T. Bohan, L. E. Arnold, 2004 .

Exercise: applications to childhood ADHD.

J. Gehricke, P. Galassetti, S. Wigal, 2013, Journal of attention disorders.

Fetal ethanol exposure diminishes hippocampal beta-adrenergic receptor density while sparing muscarinic receptors during development.

A. Amsel, S. Wigal, R. Wilcox, 1990, Brain research. Developmental brain research.

Stimulant medications for the treatment of ADHD: Efficacy and limitations

Ihab S. Soliman, J. Swanson, T. Wigal, 1999 .

Catecholamine Response to Exercise in Children with Attention Deficit Hyperactivity Disorder

J. Swanson, D. Nemet, J. Trampush, 2003, Pediatric Research.

Child and Adolescent Psychiatry and Mental Health a 13-hour Laboratory School Study of Lisdexamfetamine Dimesylate in School-aged Children with Attention-deficit/hyperactivity Disorder

Sharon B Wigal, S. Kollins, S. Wigal, 2022 .

Efficacy and Safety of Ritalin® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

J. Biederman, S. Wigal, M. Weiss, 2003, Paediatric drugs.

Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment

T. Wigal, S. Wigal, A. Childress, 2018, Postgraduate medicine.

A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD

B. Robertson, S. Wigal, G. Frick, 2019, Postgraduate medicine.

Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medication

Enrico Gratton, Sharon B Wigal, Chiara M Polzonetti, 2012, Journal of biomedical optics.

Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate.

Sharon B Wigal, Annamarie Stehli, S. Wigal, 2012, Journal of child and adolescent psychopharmacology.

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

T. Wigal, S. Schuck, S. Wigal, 2011, Journal of child and adolescent psychopharmacology.

Does Prior Exposure to Stimulants in Children with ADHD Impact Cardiovascular Parameters from Lisdexamfetamine Dimesylate?

Sharon B Wigal, Annamarie Stehli, S. Wigal, 2010, Postgraduate medicine.

A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.

S. West, T. Bohan, L. E. Arnold, 2004, Journal of child and adolescent psychopharmacology.

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

J. Swanson, J. McGough, J. Biederman, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

J. Swanson, J. McGough, J. Biederman, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.

S. Wigal, S. Chae, Robin B Steinberg-Epstein, 2010, Seminars in Pediatric Neurology.

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder

D. Oberdhan, J. T. Markowitz, S. Wigal, 2020, Neuropsychiatric disease and treatment.

Forecasting Three-Month Outcomes in a Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR) and Atomoxetine (Strattera) in School-Aged Children With ADHD

S. Faraone, S. Wigal, P. Hodgkins, 2007, Journal of attention disorders.

A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in School-Aged Children With Attention Deficit/Hyperactivity Disorder

J. McGough, J. Biederman, J. McCracken, 2005, Journal of attention disorders.

Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground.

J. Swanson, Suneel K. Gupta, S. Wigal, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

Sharon B Wigal, Ben Adeyi, S. Kollins, 2010, Child and adolescent psychiatry and mental health.

Pharmacokinetic evaluation of eltoprazine

S. Wigal, Sophie Duong, 2011, Expert opinion on drug metabolism & toxicology.

Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.

Suneel K. Gupta, S. Wigal, H. Starr, 2011, Journal of child and adolescent psychopharmacology.

A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.

J. McGough, J. Biederman, T. Spencer, 2006, Clinical therapeutics.

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

J. Swanson, C. Conners, J. Elia, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings

N. Desousa, F. Sallee, S. Wigal, 2020, Journal of child and adolescent psychopharmacology.

Effect of Reinforcement on Facial Responsivity and Persistence in Children with Attention-Deficit Hyperactivity Disorder

J. Swanson, T. Wigal, S. Wigal, 1998, Behavior modification.

Bilateral Alternating Tactile Stimulation (BLAST) and the Stress Response

C. Lathan, J. Owens, R. Findling, 2019 .

A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation

Charles D. Smith, Hon J. Yu, R. Castellani, 2015, Neuromuscular Disorders.

Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate.

J M Swanson, S B Wigal, D Udrea, 1998, Psychopharmacology bulletin.

Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder

J. Swanson, E. Sonuga-Barke, D. Coghill, 2008, European Child & Adolescent Psychiatry.

Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder

L. Greenhill, J. Owens, S. Wigal, 2016, Journal of child and adolescent psychopharmacology.

Methylphenidate (OROS® Formulation)

J. Swanson, S. Wigal, M. Lerner, 2001 .

Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.

J. Swanson, J. Biederman, L. Greenhill, 2006, Primary care companion to the Journal of clinical psychiatry.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

J. Swanson, J. Biederman, S. Wigal, 2006, The Journal of clinical psychiatry.

Perceptions of girls and ADHD: results from a national survey.

S. Wigal, P. Quinn, 2004, MedGenMed : Medscape general medicine.

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

S. Kollins, S. Wigal, L. Squires, 2009 .

Attention-deficit/hyperactivity disorder: Symptom domains, cognitive processes, and neural networks.

M. Posner, J. Swanson, D. Tucker, 1998 .

Real-World Data on: Attention Deficit Hyperactivity Disorder Medication Side Effects.

S. Wigal, A. Kalali, E. Cascade, 2010, Psychiatry.

Effects of photic stimulation on heart rate of infant rats.

A. Amsel, S. Wigal, W. Dailey, 1986, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Exercise

P. Galassetti, S. Wigal, Natasha A. Emmerson, 2013, Journal of attention disorders.

Heart-rate responses of infant rats and guinea pigs to stimulus onset and offset: tests of the generality of a bidirectional effect.

A. Amsel, S. Wigal, W. Dailey, 1985, Behavioral and neural biology.

Prevalence of ADHD symptoms in patients with congenital heart disease

T. Wigal, S. Wigal, M. Lerner, 2012, Pediatrics international : official journal of the Japan Pediatric Society.

A Randomized, Placebo-Controlled Laboratory Classroom Study of the Efficacy and Safety of Dasotraline in Children With ADHD

J. Bates, R. Goldman, Haiyuan Zhu, 2022, Journal of attention disorders.

Pharmacokinetic evaluation of eltoprazine

S. Wigal, Sophie Duong, 2011, Expert opinion on drug metabolism & toxicology.

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

S. Kollins, S. Wigal, A. Childress, 2010, Child and adolescent psychiatry and mental health.

A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation

Charles D. Smith, Hon J. Yu, R. Castellani, 2015, Neuromuscular Disorders.